Journals / Anadolu Kardiyoloji Dergisi / 2012 / Cilt: 12 - Sayı: 8

Kardiyometabolik fizyoloji ve hastalıklarda beyinden türemiş nörotrofik faktör (BDNF)

Brain derived neurotrophic factor (BDNF) in cardiometabolic physiology and diseases

Pages
684–688
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we describe the most recent advances in the functions of brain derived nerve growth factor (BDNF), a major type of neurotrophins, focusing primarily on cardiovascular and metabolic diseases. (Anadolu Kardiyol Derg 2012; 12: 684-8)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Important advances in our understanding of the relationships between adipose tissue derived peptides, namely adipokines, and their effects on cardiovascular functions have been achieved in recent years.
📊
Key Findings & Data:Growing knowledge of adipokine biology is revealing the complexity of these proteins.
💡
Conclusion & Impact:In this review, we describe the most recent advances in the functions of brain derived nerve growth factor (BDNF), a major type of neurotrophins, focusing primarily on cardiovascular and metabolic diseases. (Anadolu Kardiyol Derg 2012; 12: 684-8)
🔬Design:Review & Systematic Survey
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Important advances in our understanding of the relationships between adipose tissue derived peptides, namely adipokines, and their effects on cardiovascular functions have been achieved in recent years. Growing knowledge of adipokine biology is revealing the complexity of these proteins. Adipose tissue releases some other proteins called neurotrophins that are mainly active in central and peripheral nervous system. However, secretion and activity of these hormones are not only limited to neuronal cells and tissues, but they also take part in adipose tissue development, energy metabolism, glucose utilization, insulin sensitivity, inflammation, lipoprotein synthesis, and atherosclerosis. In this review, we describe the most recent advances in the functions of brain derived nerve growth factor (BDNF), a major type of neurotrophins, focusing primarily on cardiovascular and metabolic diseases. (Anadolu Kardiyol Derg 2012; 12: 684-8)

Özet

Son yıllarda, adipokinler olarak bilinen adipoz doku kaynaklı peptidler ve bunların kardiyovasküler fonksiyonlar üzerine etkileri üzerine önemli ilerlemeler sağlanmıştır. Adipokin biyolojisi hakkında bilgiler çoğaldıkça bu proteinlerin karmaşık görünümü aydınlatılmaktadır. Adipoz doku nörotrofinler olarak bilinen ve temel olarak santral ve periferal sinir sisteminde görev yapan diğer bazı proteinleri de salgılar. Bununla beraber, bu hormonların sekresyon ve aktivitesi sadece nöronal hücreler ve dokularla sınırlı olmayıp yağ dokusu gelişimi, enerji metabolizması, glikoz kullanımı, insülin duyarlılığı, enflamasyon, lipoprotein sentezi ve aterosklerozda da rol oynarlar. Bu derlemede majör bir nörotrofin olan beyinden türemiş nörotrofik faktör (BDNF) ile ilgili en son veriler, özellikle kardiyovasküler ve metabolik hastalıklar üzerinden irdelenmiştir. (Anadolu Kardiyol Derg 2012; 12: 684-8)

🔖

Cite This Article

KABUL, H. K., TAŞÇI, İ., AYDOĞDU, A. (2022). Kardiyometabolik fizyoloji ve hastalıklarda beyinden türemiş nörotrofik faktör (BDNF). Anadolu Kardiyoloji Dergisi, Cilt: 12 - Sayı: 8, 684–688. https://ajindex.com/articles/436454

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ahima RS, Qi Y, Singhal NS, Jackson MB, Scherer PE. Brain adipocytokine action and metabolic regulation. Diabetes 2006; 55 Suppl 2: S145-54
  2. Taşcı I, Doğru T, Naharcı I, Erdem G, Yılmaz MI, Sonmez A, et al. Plasma apelin is lower in patients with elevated LDL-cholesterol. Exp Clin Endocrinol Diabetes 2007; 115: 428-32
  3. Erdem G, Doğru T, Taşcı I, Sonmez A, Tapan S. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2008; 116: 289-92
  4. Taşcı I, Erdem G, Ozgur G, Tapan S, Doğru T, Genc H, et al. LDLcholesterol lowering increases plasma apelin in isolated hypercholesterolemia. Atherosclerosis 2009; 204: 222-8
  5. Kim HJ, Kim SK, Shim WS, Lee JH, Hur KY, Kang ES, et al. Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2008; 81: 42-9
  6. Kilic T. Is leptin an independent risk factor for development of left ventricular hypertrophy in obese hypertensive patients? Anadolu Kardiyol Derg 2008; 8: 347-9
  7. Taşcı I. Apelin, prediabetes and atherosclerosis. Exp Clin Endocrinol Diabetes 2011; 119: 457-8
  8. Doğru T, Sonmez A, Taşcı I, Yılmaz MI, Erdem G, Erturk H, et al. Plasma visfatin levels in young male patients with uncomplicated and newly diagnosed hypertension. J Hum Hypertens 2007;21:173-5
  9. Sonmez A, Celebi G, Erdem G, Tapan S, Genc H, Taşcı I, et al. Plasma apelin and ADMA Levels in patients with essential hypertension. Clin Exp Hypertens 2010; 32: 179-83
  10. Taşcı I, Erdem G, Tapan S. The relation of ADMA and apelin to endothelial dysfunction and angiogenesis in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2009; 86: e37-8
  11. Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 2001; 24: 1217-81
  12. Donovan MJ, Lin MI, Wiegn P, Ringstedt T, Kraemer R, Hahn R, et al. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 2000; 127: 4531-40
  13. Ejiri J, Inoue N, Kobayashi S, Shiraki R, Otsui K, Honjo T, et al. Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease. Circulation 2005; 112: 2114-20
  14. Cai D, Holm JM, Duignan IJ, Zheng J, Xaymardan M, Chin A, et al. BDNF-mediated enhancement of inflammation and injury in the aging heart. Physiol Genomics 2006; 24: 191-7
  15. Lommatzsch M, Zingler D,